Home » Consortium EFPIA Companies » Merck Healthcare KGaA, Germany

Merck Healthcare KGaA, Germany

Partner Description

Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 53,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials. For the Biopharma business of Merck, research and development focus on the fields of oncology, immuno-oncology, and immunology. The Merck Healthcare business spans across oncology, immuno-oncology, and immunology, as well as neurology, fertility, endocrinology and general medicine.

The Chemical and Preclinical Safety department is located in Darmstadt, Germany, and will be leading Merck Healthcare KGaA contributions to the imSAVAR project.